Both buying and selling activities occurred, with varied investment entities like
Dark Forest Capital Management LP and
DoubleLine ETF Adviser LP purchasing and selling shares of
Kimberly-Clark Co. respectively. Notably,
Stacey Valy Panayiotou was appointed as Chief Human Resources Officer, indicating potential shifts in the company's talent strategy. The company also announced a presentation at the
Piper Sandler's Growth Frontiers Conference. It garnered attention for its upcoming US$1.26 dividend, with investors advising due consideration. Furthermore, the company boosted its 2025 outlook following relatively strong Q2 results, showing
record sales growth. Plans to invest over
$2 Billion to expand US manufacturing and fuel growth have been revealed. A proactive stance against prostate cancer was displayed with a $300K research initiative in partnership with MLB stars. Still, caution was signaled as insiders sold US$2.6m of the stock. Lastly, Kimberly-Clark is
switching its U.S. stock exchange listing to Nasdaq, ending its legacy with NYSE.
Kimberly-Clark Corp KMB News Analytics from Sat, 04 Jan 2025 08:00:00 GMT to Sat, 06 Sep 2025 22:07:01 GMT -
Rating 7
- Innovation 5
- Information 7
- Rumor -3
